生物标志物能否指导溶瘤病毒免疫疗法？
Can Biomarkers Guide Oncolytic Virus Immunotherapy?
作者信息
Kaufman Howard L
机构信息
Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
Clin Cancer Res. 2021 Jun 15;27(12):3278-3279. doi: 10.1158/1078-0432.CCR-21-0660. Epub 2021 Apr 13.
Abstract
Defects in tumor cell IFNγ signaling is associated with resistance to immune checkpoint inhibitors. Recently, these defects were found to confer increased sensitivity to oncolytic virus infection. Differential expression of innate sensing elements in tumor cells may serve as predictive biomarkers of oncolytic virus immunotherapy in patients with cancer..
摘要
肿瘤细胞干扰素γ信号通路的缺陷与对免疫检查点抑制剂的耐药性有关。最近，发现这些缺陷会使肿瘤细胞对溶瘤病毒感染的敏感性增加。肿瘤细胞中固有传感元件的差异表达可能作为癌症患者溶瘤病毒免疫治疗的预测生物标志物。
Zotero 插件